Picture of Vext Science logo

VEXT Vext Science Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Annual income statement for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue18.522.325.237.235.4
Cost of Revenue
Gross Profit9.179.471016.520.9
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses12.918.722.630.326.3
Operating Profit5.573.622.616.989.08
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes4.883.672.646.826.7
Provision for Income Taxes
Net Income After Taxes3.752.792.134.9910.9
Net Income Before Extraordinary Items
Net Income3.752.792.134.9910.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income3.752.792.134.9910.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.2010.1230.0480.0340.069